StackTerminal.Health

BETA
@drwillcole

There’s a fascinating conversation buzzing right now across neuroscience and wel

MIXED
TrustworthinessMixed

The reel accurately describes the use of GLP-1 agonists like semaglutide for weight loss and suggests potential effects on addiction, which is supported by some studies. However, the claim about these supplements affecting the ability to fall in love is speculative and lacks scientific evidence.

Creator history
See @drwillcole's full track record — how often their claims check out.
PRO
Detected Supplements (3)
semaglutide
IngredientNo evidence data — unverifiable

This ingredient is not in our library. We cannot assess claims about it.

tirzepatide
IngredientNo evidence data — unverifiable

This ingredient is not in our library. We cannot assess claims about it.

Retatrutide (LY-343794)"retatrutide" in reel
Low
Retatrutide (LY-343794)Supported

GLP-1 agonists can decrease food cravings and help with weight loss.

Retatrutide has been shown to produce significant weight loss, supporting the claim about GLP-1 agonists reducing food cravings.

Retatrutide (LY-343794)Overstated

GLP-1 agonists can decrease alcohol cravings, drug cravings, and other types of addiction.

While there is some research suggesting GLP-1 agonists may affect addiction pathways, the evidence is not conclusive enough to broadly claim they decrease various cravings.

Retatrutide (LY-343794)Unsupported

GLP-1 agonists impact the desire for love and relationships.

There is no scientific evidence supporting the claim that GLP-1 agonists affect the desire for love or relationships.

Transcript
Auto-generated from the reel audio.
Millions of people take GLP-1 agonists to lose weight, but are we causing a generation of people to lose love? Peptides like semaglutide and the brand names like Ozempic, Terzepizide, Redetrutide, these different derivatives of GLP-1 agonists work on decreasing food cravings. That's how people lose weight. And there's also exciting science showing that GLP-1 agonists can be used to decrease alcohol cravings, drug cravings, and other types of addiction because they all work upon dopamine pleasure reward centers of the brain. But do you know the part of the brain that this also impacts? It's the same part of the brain that impacts the desire for love, the cravings for relationship. So are we creating a whole generation of people unable to fall in love or if you're in a relationship, you're falling out of love. It's causing relationship problems. And with the rise of AI and people falling in love with their chatbot, is this a recipe for disaster? Of course, more studies need to be done. This is understanding the mechanism of how these peptides work, but we don't know for sure. But I had a deep dive conversation with my clinical team of how we utilize peptides in a really successful way. Cyclical, microdose, not just GLP-1 agonists, but other types of peptides as well. I think there's a sweet smart spot of how to use peptides. In the West, we like to overcorrect, overdo everything. If a little is good, the more is better. Comment pod below if you want me to send you a deeper dive discussion on the peptide protocols I've seen work the best for telehealth patients. And let me know in the comments, do you think that since maybe you or someone you know or your partner started using GLP-1s, has it impacted your relationship negatively?
Caption

There’s a fascinating conversation buzzing right now across neuroscience and wellness communities, around GLP-1 agonists—like Ozempic, Tirzepatide, and Retatrutide—don’t just tame food cravings and other addictions with newer research (alcohol, gambling, etc.); could they be dialing down the brain’s core “wanting” circuitry in the same reward pathways that light up during falling in love, relationships. and romantic attachment. The hypothesis is that by modulating these overlapping dopamine-driven systems, these medications could potentially blunt the intense craving and euphoria of new love or even soften feelings in existing relationships—prompting real questions about how widespread, longterm, higher dose use might reshape human connection at a neurobiological level. What do you think about this emerging discussion? Drop your thoughts (and any personal experiences) in the comments below—I’d love to hear them! 👉🏽 Comment POD below if you want me to send you my full clinical take on this and on how I’ve seen GLP-1 agonists and other peptides work the best clinically longterm. #ArtOfBeingWell